Experimental Physiology
	

Celebrating 100 years
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Experimental Physiology 89.2 pp 163-172
DOI: 10.1113/expphysiol.2003.026732
© The Physiological Society 2004
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
89/2/163    most recent
expphysiol.2003.026732v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kettlewell, S.
Right arrow Articles by Smith, G. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kettlewell, S.
Right arrow Articles by Smith, G. L.
Related Collections
Right arrow Heart/Cardiac Muscle

The electrophysiological and mechanical effects of 2,3-butane-dione monoxime and cytochalasin-D in the Langendorff perfused rabbit heart

S. Kettlewell*,1, N. L. Walker*,2, S. M. Cobbe2, F. L. Burton2 and G. L. Smith1

1 Institute of Biomedical and Life Science, University of Glasgow, University Avenue, Glasgow, G12 8QQ, Scotland, UK2 Section of Cardiology, Division of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow Royal Infirmary, Scotland, UK


    Abstract
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
Procedures that reduce contraction are used to facilitate optical measurements of membrane potential, but it is unclear to what extent they affect the excitability of the heart. This study has examined the electrophysiological consequences of a range of extracellular [Ca2+] (0.7–2.5 mmol l–1), 2,3-butane-dione monoxime (BDM; 1–20 mmol l–1) and cytochalasin-D (Cyto-D; 1–5 µmol l–1). Methods. Monophasic action potentials (MAPs) were recorded from the basal epicardial surface of the left ventricle of isolated rabbit hearts. Conduction delay (CD) and time to 90% repolarisation of the monophasic action potential (MAPD90) were measured. The effects of BDM and Cyto-D on restitution were studied at a [Ca2+] of 1.9 mmol l–1. Restitution curves for MAPD90 were generated using a standard S1–S2 protocol. Results. All manoeuvres decreased left ventricular developed pressure (LVDP): 0.7 mmol l–1 Ca2+ to 74.0 ± 6.1%, 20 mmol l–1 BDM to 4.5 ± 1.0%, and 5 µmol l–1 Cyto-D to 12.8 ± 3.5% of control value. CD decreased from a control value (33.3 ± 1.0 ms, n= 16) to 93.0 ± 2.2% in 0.7 mmol l–1 Ca2+, but increased to 133.7 ± 10.5% in 20 mmol l–1 BDM and 127.4 ± 10.6% in 5 µmol l–1 Cyto-D. At 350 ms pacing cycle length, MAPD90 (control = 119.6 ± 1.7 ms n= 16) was prolonged by reduced extracellular [Ca2+]. BDM had no effects on MAPD90 at control pacing rates. Cyto-D caused a significant prolongation (to 115.0 ± 3.0% of control, n= 6) at the highest concentration studied (5 µmol l–1). Both BDM (20 mmol l–1) and Cyto-D (3 µmol l–1) flattened the restitution curves but neither agent altered maximum MAPD90. Conclusions. Extracellular [Ca2+] of 1.9 mmol l–1 in conjunction with a moderate dose of Cyto-D (3 µmol l–1) reduced contractility with minimal effects on action potential duration and conduction at a fixed pacing cycle length. However, both BDM and Cyto-D had pronounced effects on electrical restitution.

(Received 17 October 2003; accepted after revision 3 December 2003)
Corresponding author G. L. Smith: Institute of Biomedical and Life Sciences, University of Glasgow, Glasgow, G12 8QQ, UK.  E-mail: g.smith{at}bio.gla.ac.uk


    Introduction
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
Developments in imaging systems and fluorescence probes have allowed the optical mapping of electrical activity of the mammalian myocardium (Salama & Choi, 2000). Currently, these techniques require a static field of study; contraction results in movement of the myocardium that adds a motion artefact to the optical signal. Many techniques have been employed to reduce motion artefact including both pharmacological (Baker et al. 2000; Biermann et al. 1998; Jalife et al. 1998; Lee et al. 2001; Liu et al. 1993) and mechanical constraints (Salama, 2001), but the effectiveness of these manoeuvres is highly species dependent.

2,3-butane-dione monoxime (BDM) is an inhibitor of myofibrillar ATPase (Blanchard et al. 1990), an action that prevents myocardial contraction despite an increase of intracellular [Ca2+]. BDM has therefore been widely used to eliminate motion in cardiac muscle preparations. However, this treatment is not without electrophysiological consequences. Transgenic mouse whole heart studies showed that 15 mmol l–1 BDM reduced conduction velocity (Verrecchia & Herve, 1997) and doubled action potential duration (Baker et al. 2000). In contrast, in swine (Lee et al. 2001) right ventricle, and in guinea pig and sheep (Liu et al. 1993) ventricle, demonstrated that 5-20 mmol l–1 BDM reduced APD90 in a dose dependent manner. BDM has also been shown to flatten the electrical restitution curve in swine (Lee et al. 2001) and canine (Riccio et al. 1999) ventricles. A recent study suggests that 20 mmol l–1 BDM flattens the restitution curve in rabbit (Banville & Gray, 2002), but the dose dependence of this effect has not been studied.

Cytochalasin-D (Cyto-D), an agent that impairs actin filament polymerization (Krucker et al. 2000), is also widely used. In isolated canine ventricular muscle, Biermann et al. (1998) demonstrated that Cyto-D at concentrations up to 80 µmol l–1 had no significant effect on cardiac repolarisation while having a profound, irreversible negative inotropic effect. Jalife et al. (1998) found that 20–80 µmol l–1 Cyto-D eliminated contraction in the mouse heart, although they also observed significant membrane hyperpolarisation and action potential prolongation. In one study that looked at the dynamics of ventricular fibrillation in the swine right ventricle, 10–40 µmol l–1 Cyto-D did not effect restitution (Lee et al. 2001), while in another study 10 µmol l–1 CytoD had minimal effects on restitution in isolated rabbit hearts (Banville & Gray, 2002).

The aim of this study was to investigate electrophysiological and mechanical effects of BDM and Cyto-D in the rabbit heart in an effort to develop a protocol to allow routine optical recording of action potentials from the epicardial surface of the heart.


    Methods
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
Langendorff perfusion

Male New Zealand White rabbits (2.5–3 kg) were sacrificed by intravenous administration of sodium pentobarbitone (100 mg kg–1) with 1000 IU heparin into the left marginal ear vein. The heart was rapidly excised and perfused in Langendorff mode with filtered (5 µm pore) modified, buffered, Tyrode's solution within 3 min of removal from the animal. The buffer solution consisted of (mmol l–1): 120.9 NaCl, 5 KCl, 2.5 CaCl2, 1 MgSO4, 0.7 KH2PO4, 24.8 NaHCO3, and 11 glucose. The solution was equilibrated with 95% O2/5% CO2 and heated to 37°C. The heart was perfused at 40 ml min–1 using a Gilson Minipuls 3 peristaltic pump (Gilson, Inc., Middleton, WI, USA). Preliminary measurements confirmed the temperature (36–37°C) and pH (pH 7.35–7.45) of the Tyrode's solution emerging from the aortic cannula.

Experimental protocols

The right atrium was dissected from the heart to remove the sino-atrial node. The atrio-ventricular node was crushed to destroy its pacemaker activity. Under these circumstances, the intrinsic rate of the heart decreased to ~1 Hz. The heart was then paced at twice diastolic threshold and at a constant cycle length of 350 ms via a pair of bipolar pacing electrodes inserted at the base of the right ventricle. Intraventricular pressure was monitored with a fluid-filled latex balloon inserted into the apex of the left ventricle. The balloon was connected via a 6F cannula to a pressure transducer (Triton Technology Inc., San Diego, CA). The volume of the balloon was adjusted to give zero end diastolic pressure. To allow stabilisation, the hearts were perfused in standard Tyrode's solution for approximately 20 min. Perfusion pressure was monitored via a second transducer placed in series with the aortic cannula. Average perfusion pressure measured during diastole under control conditions ranged from 17–35 mmHg (mean value 27.4 ± 2.6; n= 8).

Perfusion protocols

Reduced extracellular [Ca2+].  Perfusion was initially with normal Tyrode's (containing 2.5 mmol l–1 Ca2+) solution for 5 min. Then a series of [Ca2+] changes were made to 0.7, 1.4 and 1.9 (mmol l–1). The heart was perfused for 10 min at each of these concentrations. Contractility was then restored by perfusion with normal Tyrode's solution for 20 min.

BDM.  BDM (Sigma Aldrich, UK) was dissolved in normal Tyrode's solution prior to each experiment. Perfusion was initially with normal Tyrode's solution then BDM concentration was changed at 5-min intervals from (mmol l–1): 20, 10, 5, 3, 2, and 1. Finally the heart was perfused with Tyrode's solution for 15 min to monitor recovery. Preliminary investigations demonstrated that a reducing order of concentration of BDM avoided arrhythmias in the washout phase.

Cyto-D.  Cyto-D was dissolved in DMSO to give a 10 mmol l–1 stock solution. The appropriate quantity of stock Cyto-D was added to normal Tyrode's solution prior to each experiment. Since Cyto-D is a photosensitive compound, these experiments were carried out in darkness. Perfusion solution containing Cyto-D was aerated and re-circulated for 20 min prior to recordings being taken. Perfusion was initially with normal Tyrode's solution for 5 min followed by a series of Cyto-D concentrations (µmol l–1): 1, 3, and 5. Washout was with normal Tyrode's solution for 60 min.

Monophasic action potential recordings

A Franz contact catheter electrode (non-polarisable Ag–AgCl electrode, 2 mm diameter, Boston Scientific/EP Technologies, San Jose, CA, USA) recorded monophasic action potentials (MAPs) from the basal region of the left ventricle. MAPs were digitised at a rate of 1 kHz and analysed off line using a locally developed computer programme. The time of the MAP upstroke was taken as the time of maximum rate of depolarisation (dV/dtmax). Measurements of conduction delay (CD) (time from stimulus artefact to the dV/dtmax of the MAP upstroke) and MAP duration (time between dV/dtmax and 90% repolarization, MAPD90) were made.

Restitution protocols

Electrical restitution was investigated in hearts perfused with Tyrode's solution (1.9 mmol l–1 Ca2+) with either 3 µmol l–1 Cyto-D or 20 mmol l–1 BDM. The heart was stimulated with a basic drive train of 16 stimuli at 350 ms intervals followed by an extra stimulus, S2. The S1–S2 interval was increased by 5 ms between 70 and 150 ms, 10 ms between 150 and 350 ms, and 50 ms between 350 and 600 ms. Graphs of MAPD90 of the S2-induced MAP against diastolic interval (DI) were fitted with an exponential restitution curve: MAPD90={alpha}–ß* e–DI/{tau} using Microcal Origin version 6.1 (OriginLab Corporation, MA, USA). The constants {alpha}, ß and {tau} were measured from each dataset collected before and after perfusion with the experimental solutions. The maximum slopes of the restitution curves were obtained analytically by computing the derivative of the restitution fits to the above equation (Banville & Gray, 2002). The maximum MAPD90 (MAPD90max) values were taken from the mean of the MAPD90 values measured at 550 ms and 600 ms S1–S2 intervals.

Optical mapping

Membrane potential records were obtained using an optical mapping array. The heart was immobilised with a combination of 1.9 mmol l–1 Ca2+ Tyrode's and 3 µmol l–1 Cyto-D. The heart was placed in a custom-made perspex chamber. This further reduced motion artefact and allowed the temperature of the bathing solution to be controlled. The heart was loaded with 100 µl of the voltage sensitive dye RH-237 (Molecular Probes, Europe BV, Leiden, The Netherlands), dissolved in DMSO (1 mg ml–1) administered through the coronary perfusate, via a port in a bubble trap.

Light from a 150 W Xenon arc lamp (Cairn Research Ltd, Kent, UK) was passed through a 575 nm short-pass filter (Comar Instruments, Cambridge, UK) and shone on the surface of the heart. Light emitted from the stained preparation was collected with a camera lens (Nikon 85 mm, f1:1.4), passed through a 645 nm long-pass filter, and the image focused on a 16 x 16 photodiode array (C4675-102, Hamamatsu Photonics Corporation, NJ, USA). The four corner channels were reserved for other signals so optical signals were acquired from 252 of 256 diodes (see Fig. 7A). Digitised data samples were stored on hard disk and analysed using software written in IDL (Interactive Data Language, Research Systems Inc., CO, USA). Four optical action potentials from the basal region of the array were compared to a contact catheter obtained MAP from a comparable region of the same heart in n= 4 hearts (see Fig. 7).



View larger version (31K):
[in this window]
[in a new window]
 
Figure 7
A, example of RH-237 fluorescence recorded from an optical array. 252 action potentials obtained simultaneously from the epicardial surface of the left ventricle. B, signals from the 4 pixels indicated in A by the highlighted box. C, monophasic action potential recording from the same region of the same heart.

 
Data acquisition and statistical analysis

Recordings taken from the final 60 s of each perfusion period were analysed for MAPD90 and CD. Left ventricular developed pressure (LVDP) was represented as a percentage of the maximum control value. Repeated measures ANOVA was used to compare values of LVDP and of basic electrophysiological parameters (CD and MAPD90) and Student's t-test (paired data) for the restitution analysis. Data were expressed as the mean ± standard error.


    Results
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
MAP and LVDP recordings

Figure 1A shows an example of recordings of a MAP from a catheter electrode placed on the basal epicardium. Below the trace is the derivative of the voltage signal. As indicated, the MAPD90 value was derived from the time between the peak dV/dt signal and the time at which the MAP had decayed to 90% of its original value. The trace shown in Fig. 1B is a record of LVDP from the intraventricular balloon. The LVDP recorded in this study under the standard conditions (pacing cycle length of 350 ms, extracellular Ca2+ of 2.5 mmol l–1, end-diastolic pressure 0 mmHg) was 41.7 ± 6.7 mmHg (n= 7); similar values were reported for isolated Langendorff perfused rabbit hearts perfused under similar conditions (Ng et al. 1998). Mean MAPD90 under these conditions was 118.2 ± 2.1 ms (n= 7).



View larger version (15K):
[in this window]
[in a new window]
 
Figure 1
Examples of monophasic action potential and left ventricular pressure (LVDP) recordings. The stimulus artefact (SA) associated with right ventricular pacing is marked by an arrow. The differential of the voltage trace is shown below the signal.

 
Effects of reduced extracellular [Ca2+]

As shown in Fig. 2, decreasing extracellular [Ca2+] from 2.5 mmol l–1 to less than 1.4 mmol l–1 caused a marked prolongation of the MAPD90, but only a small decrease in CD. At 0.7 mmol l–1 Ca2+, significant depression of LVDP to 74.0 ± 6.1% (n= 6) of control level occurred along with an increase in MAPD90 (mean value 162.8 ± 7.2 ms n= 6) Subsequent perfusion of the heart with normal Tyrode's solution (2.5 mmol l–1 Ca2+) resulted in recovery of electrical and mechanical activity. The relationship between extracellular [Ca2+] and these baseline electrical parameters suggests that 1.9 mmol l–1 is approximately the lowest extracellular [Ca2+] that can be used without marked electrophysiological effects.



View larger version (13K):
[in this window]
[in a new window]
 
Figure 2
The relative effect of altered extracellular [Ca2+] on end-systolic LVDP (A), MAPD90 (B) and conduction delay (C). n= 6 ***P < 0.001 **P < 0.01 *P < 0.05.

 
Effects of BDM and Cyto-D on LVDP

Figure 3A illustrates the effect of both BDM and Cyto-D on LVDP. The steady-state values and the degree of recovery after removal of either agent are summarised in Fig. 3B. BDM (3-20 mmol l–1) causes a significant dose-dependant depression of LVDP. 3 µmol l–1 Cyto-D reduced LVDP to 20.1 ± 5.3% of control values.



View larger version (27K):
[in this window]
[in a new window]
 
Figure 3
The relative effect of BDM and Cyto-D on LVDP. A, records of LVDP illustrating the effect of 20 mmol l–1 BDM (i) and 5 µmol l–1 Cyto-D (ii). B, dose dependence curves for 1–20 mmol l–1 BDM (i) and 1–5 µmol l–1 Cyto-D (ii). n= 6. ***P < 0.001 **P < 0.01 *P < 0.05.

 
Effects of BDM and Cyto-D on MAPD90 and conduction delay

Under these conditions, the highest BDM concentration (20 mmol l–1) increased the CD (normally 33.3 ± 1.0 ms, n= 16) to 132.7 ± 10.52% (n= 6) of control value. The effects of BDM on MAPD90 were variable and not statistically significant at any concentration studied (Fig. 4). Cyto-D increased MAPD90 at higher concentrations (5 µmol l–1). At this concentration CD was also significantly increased to 118.7 ± 9% of control value, as shown in Fig. 4B.



View larger version (20K):
[in this window]
[in a new window]
 
Figure 4
The relative effect of BDM and Cyto-D on myocardial electrophysiology. A, MAPD90. B, conduction delay (CD). n= 6. ***P < 0.001 **P < 0.01 *P < 0.05.

 
On returning to normal Tyrode's after perfusion with BDM, the LVDP and CD recovered, although the MAPD90 frequently remained lower than the value prior to exposure to BDM, although this was not significant. In the case of Cyto-D, despite a prolonged period of washout (60 min) full recovery MAPD90 and LVDP did not occur (see Figs 3B and 4B), but CD was restored to normal values.

Effects of BDM and Cyto-D on electrical restitution

The measurements of electrical restitution were made in the presence of 1.9 mmol l–1 Ca2+ using a dose of BDM (20 mmol l–1) or Cyto-D (3 µmol l–1) that the earlier data had indicated would be the best compromise between maximal inhibition of LVDP and minimal effects on MAPD90 and CD. Electrical restitution was assessed using an extra stimulus (S2) as indicated in Fig. 5A at varying times during diastole. An example of the restitution data for 20 mmol l–1 BDM is shown in Fig. 5B, and for 3 µmol l–1 Cyto-D in 5C. These data illustrate the monotonic relationship between MAPD90 and the preceding diastolic interval. The data were fitted by an exponential curve with parameters {tau}, {alpha} and ß (see Methods). The maximum slope was derived from the restitution curve fits. As shown in Fig. 5B, BDM (20 mmol l–1) increased {tau}, i.e. reduced the maximum slope of the restitution curve, a result that confirms the findings of earlier studies (Banville & Gray, 2002; Riccio et al. 1999), and reduced the MAPD90max. The average data shown in Fig. 6A(i) and B(i) indicate a significant reduction in maximum slope and increase in {tau} by 20 mmol l–1 BDM. Figure 6C(i) indicates that MAPD90max was not significantly different. Figure 6A(ii), B(ii) and C(ii) summarise the effects of Cyto-D on electrical restitution, as with BDM, the maximum slope was decreased and {tau} increased, but there was no significant effect on MAPD90max.



View larger version (19K):
[in this window]
[in a new window]
 
Figure 5
The effect of 20 mmol l–1 BDM and 3 µmol l–1 Cyto-D on electrical restitution. A, an example MAP recording during a restitution protocol. B, the effect of 20 mmol l–1 BDM on electrical restitution. C, illustrates the effects of 3 µmol l–1 Cyto-D on restitution. Solid lines in B and C represent best fit to the following equation: MAPD90={alpha}–ß* e–DI/{tau}.

 


View larger version (36K):
[in this window]
[in a new window]
 
Figure 6
The effect of 20 mmol l–1 BDM and 3 µmol l–1 Cyto-D on the maximum slope, time constant ({tau}) and the maximum MAPD90 (MAPD90max) derived from the electrical restitution curves (Fig. 5); n= 5 BDM & Cyto-D. *P < 0.05, paired t-test.

 
Optical mapping validation study

MAPs recorded from a catheter electrode were compared with those recorded from optical measurements in n= 4 hearts. Figure 7A shows optical signals recorded from the basal-epicardial surface of the left ventricle. Movement artefacts were minimised by perfusion with a combination of 1.9 mmol l–1 Ca2+ Tyrode's and 3 µmol l–1 Cyto-D. Highlighted within the array are 4 adjacent basal pixels, the individual signals are shown in detail in Fig. 7B. Measurement of action potential duration (APD) was made at 50% and 75% repolarisation to avoid artefact as a result of minor movement artefacts contaminating the final 10-15% of the repolarisation (Fig. 7B). Then a single MAP recording was made using the catheter electrode at the same site on the epicardial surface from which optical recordings were recorded. As shown in Fig. 7B, the time course of these two recordings is very similar. On average, APD50, APD75 and APD90 recorded using optical techniques were very close to those recorded using a catheter MAP electrode (106 ± 6.0%, 105 ± 2.4% and 109 ± 2.1% respectively). Paired t-test applied to the data at each point in the repolarisation phase revealed that only the APD90 values by the optical methods were significantly longer than the comparable MAP recording. These data indicate that MAP duration and APD values recorded with optically agree well over the majority of the repolarisation phase. The significant difference emerging at APD90 may be due to residual movement artefact.


    Discussion
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
The purpose of this study was to investigate the electrophysiological effects of various pharmacological interventions that are known to reduce whole heart contractility. Eliminating or at least minimising contraction is desirable to reduce motion artefact in optical signals recorded using fluorescent indicators. Mechanical restraint (Salama, 2001) may help to reduce motion artefact to an acceptable level during short or intermittent recordings, but this strategy is less successful for continuous recordings. In particular, if part of the restraint involves pressing the heart against a glass window, this procedure can lead to local ischaemia if maintained for long periods (>10 s). Therefore it is desirable to discover a pharmacological approach that would suppress movement but not affect the electrical activity of the heart.

Electrical and mechanical effects of lowered [Ca2+]

Reduction of extracellular Ca2+ to 1.9 mmol l–1 i.e. 76% of control levels (2.5 mmol l–1) had no significant effect on systolic LVDP, CD or MAPD90. A significant reduction in systolic LVDP was observed at the non-physiological Ca2+ concentration of 0.7 mmol l–1, accompanied by dramatic changes in electrophysiological parameters. These results suggest that lowering extracellular [Ca2+] to 1.9 mmol l–1 can be achieved with relatively minor effects on whole heart electrophysiology or LVDP. Further reductions of [Ca2+] decrease LVDP but also have dramatic effects on MAPD90 and CD. This range of electrophysiological effects is not surprising given the essential role of extracellular Ca2+ for the function of cardiac muscle cells, Purkinje cells of the cardiac conduction system and nodal cells of the atrio-ventricular node. The prolongation of APD90 observed on lowering extracellular [Ca2+] is due to a combination of reduced Ca2+ influx via L-type Ca2+ channels and effects on a range of Ca2+ sensitive currents involved in the later phases of the action potential. These currents include the Na+/Ca2+ exchanger (Eisner & Lederer, 1989), the Ca2+ sensitive Cl current (Hiraoka et al. 1998), Ca2+ sensitive non-selective current (Mubagwa et al. 1997), the transient outward current (Nitta et al. 1994) and the Ca2+ sensitive component of the delayed rectifier (Barrett et al. 1982). Lowering extracellular [Ca2+] to ~45% had little effect on contractility but a profound effect on MAPD and CD. Therefore reducing extracellular [Ca2+] alone is a poor method for uncoupling electrical activity and contraction. The lowest extracellular [Ca2+] studied that can be used without effects on cardiac electrophysiology is 1.9 mmol l–1.

Electrical and mechanical effects of BDM

The concentration dependence of the depressive effects of BDM on LVDP is similar to that reported in a number of cardiac preparations including human myocardium (Blanchard et al. 1990; Schwinger et al. 1993; Wiggins et al. 1980). In this study however, there were no effects of BDM on MAPD90 at the standard cycle length (350 ms). Previous reports on canine myocardium reported pronounced action potential shortening with 10 and 20 mmol l–1 BDM (Riccio et al. 1999). A separate study indicated that the ability of BDM to shorten APD was small and dependent on cycle length (Liu et al. 1993). At cycle lengths close to physiological, concentrations of BDM up to 15 mmol l–1 had no effect on guinea pig APD. This is in agreement with the absence of a significant effect of BDM observed in this study at a pacing cycle length close to physiological resting heart rate. As shown in Fig. 5, BDM reduced (flattened) the slope of the restitution relation. The average {tau} of the exponentially fitted restitution curves was significantly increased by 20 mmol l–1 BDM and the maximum slope was significantly reduced. Similar results with BDM were reported in swine (Lee et al. 2001), rabbit (Banville & Gray, 2002) and canine myocardium (Riccio et al. 1999). This study by Riccio et al. went on to show that drugs that reduce the slope of the restitution curve play a role in the prevention of ventricular fibrillation and the conversion of fibrillation to ventricular tachycardia. Clearly this has implications for the use of BDM as a motion artefact inhibitor. BDM has been reported to affect a number of ion channels, pumps and exchangers in cardiac tissue. Inhibition of L-type Ca2+ channels (Ferreira et al. 1997), Na+/Ca2+ exchanger (Watanabe et al. 2001), and transient outward K+ channel (Coulombe et al. 1989) have been reported. BDM also has actions on intracellular targets including the SR Ca2+ release channel (Eisner & Lederer, 1989) and Ca2+ pump (Steele & Smith, 1993).

Some or all of these actions may account for the effects of BDM on the ventricular myocytes and may play a role in the ability of BDM to increase CD. A study on isolated tissue reported a decrease in A-V node conduction delay by 10 mmol l–1 BDM (Cheng et al. 1997). This suggests that the increased CD observed in this study may be a result of an effect of BDM on the ventricular conduction system. Further work is needed to distinguish the source of the delayed conduction with BDM.

Mechanical and electrical effects of cytochalasin-D

Cyto-D substantially depressed LVDP at concentrations as low as 3 µmol l–1, which were much lower than used previously. Previous studies have used concentrations as high as 10–40 µmol l–1 in swine (Lee et al. 2001) and 60–80 µmol l–1 in canine myocardium (Biermann et al. 1998). In both of these studies, Cyto-D was reported to have negligible effects on action potential duration and myocardial conduction velocity. These results are in contrast to the current study where significant prolongation of MAPD90 and CD were observed in 5 µmol l–1 Cyto-D, a result supported by a recent independent study in the rabbit (Hayashi et al. 2003). These effects limit the concentration of Cyto-D that can routinely be used to uncouple contraction from electrical activity in rabbit myocardium to 1–3 µmol l–1. At these concentrations Cyto-D does not eliminate contraction but has minimal electrophysiological effects. The observed effect of Cyto-D on the electrical restitution curve is in contrast to previous reports. An initial study suggested that Cyto-D had no significant effects on the slope of the restitution curve (Lee et al. 2001). However, subsequent reports indicate that the maximum slope is increased by Cyto-D in the rabbit (Banville & Gray, 2002; Hayashi et al. 2003). In the current study, Cyto-D flattened the restitution curve (decreased maximum slope). The reason for the disparity with recent work is unknown; the stimulus protocols used in these different published studies to uncover the restitution curve differ from each other and from the current study. Alternatively, the current study used exclusively male rabbits whilst Hayashi et al. (2003) used female rabbits. It is recognised that there are differences in the repolarisation characteristics of male and female mammals (Smetana et al. 2002).

Regardless of the form of the effect, changes in the restitution curve due to BDM or Cyto-D indicate that these agents are not suitable for investigations of restitution parameters in the rabbit. Furthermore, changes in the shape of the restitution curve have marked effects on the ability of the myocardium to convert ventricular fibrillation to tachycardia. Therefore studies of re-entrant arrhythmias in rabbit myocardium in the presence of these agents must be interpreted with caution.

Optical mapping validation study

A limited validation study was performed to verify that the action potential duration measured using MAP recordings coincided with those recorded from RH 237 fluorescence. As shown in Fig. 7 and the accompanying data, recordings from both techniques showed remarkable agreement. Comparisons of the APD50 and APD75 values from a series of hearts were not significantly different. Measurements of APD90 from optical recordings were significantly longer than the corresponding values measured by MAP recording. Assuming that these latter recordings are less susceptible to artefacts, the data suggest that the remaining movement artefact and poorer signal-to-noise ratio of optical recordings reduce the reliability of the APD90 measurements from optical data.

Summary

From this study Cyto-D (3 µmol l–1) and BDM (20 mmol l–1) are effective agents at reducing contractility in whole rabbit hearts. Cyto-D was the preferred since at 3 µmol l–1, the effects on MAPD90 and conduction delay were minimal, whereas 20 mmol l–1 BDM significantly delayed conduction. At these concentrations, neither agent affected action potential duration at physiological cycle lengths (350 ms). However, both agents affected electrical restitution, and so caution must be exercised when using these agents to study phenomena where restitution parameters are critical.


    Footnotes
 
* Shared first authorship. Back


    References
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 References
 
Baker LC, London B, Choi BR, Koren G & Salama G (2000). Enhanced dispersion of repolarization and refractoriness in transgenic mouse hearts promotes reentrant ventricular tachycardia. Circ Res 86, 396–407.[Abstract/Free Full Text]

Banville I & Gray RA (2002). Effect of action potential duration and conduction velocity restitution and their spatial dispersion on alternans and the stability of arrhythmias. J Cardiovascular Electrophysiol 13, 1141–1149.[CrossRef][Medline]

Barrett JN, Magleby KL & Pallotta BS (1982). Properties of single calcium-activated potassium channels in cultured rat muscle. J Physiol 331, 211–230.[Abstract/Free Full Text]

Biermann M, Rubart M, Moreno A, Wu JS, JosiahDurant A & Zipes DP (1998). Differential effects of cytochalasin D and 2,3 butanedione monoxime on isometric twitch force and transmembrane action potential in isolated ventricular muscle: implications for optical measurements of cardiac repolarization. J Cardiovascular Electrophysiol 9, 1348–1357.[Medline]

Blanchard EM, Smith GL, Allen DG & Alpert NR (1990). The effects of 2,3-butanedione monoxime on initial heat, tension and aequorin light output of ferret papillary muscles. Pflugers Arch. 416, 219–221.[CrossRef][Medline]

Cheng YN, Mowrey K, Efimov IR, VanWagoner DR, Tchou PJ & Mazgalev TN (1997). Effects of 2,3-butanedione monoxime on atrial-atrioventricular nodal conduction in isolated rabbit heart. J Cardiovascular Electrophysiol 8, 790–802.[Medline]

Coulombe A, LeFevre IA, Deroubaix E & Coraboeuf E (1989). Effect of diacetyl monoxime on transient outward current in rat ventricular myocytes. Pflugers Arch. 414, S173–S174.

Eisner DA & Lederer WJ (1989). The electrogenic sodium-calcium exchange. In Sodium-Calcium Exchange, ed. Allen T, Noble D & Reuter H, pp. 178–207. Oxford University Press, Oxford.

Ferreira G, Artigas P, Pizarro G & Brum G (1997). Butanedione monoxime promotes voltage-dependent inactivation of L-type calcium channels in heart. Effects on gating currents. J Mol Cellular Cardiol 29, 777–787.[CrossRef][Medline]

Hayashi H, Miyauchi Y, Chou CC, Karagueuzian HS, Chen PS & Lin SF (2003). Effects of Cytochalasin D on electrical restitution and the dynamics of ventricular fibrillation in isolated rabbit heart. J Cardiovascular Electrophysiol 14, 1077–1084.[CrossRef][Medline]

Hiraoka M, Kawano S, Hirano Y & Furukawa T (1998). Role of cardiac chloride currents in changes in action potential characteristics and arrhythmias. Cardiovascular Res 40, 23–33.[Abstract/Free Full Text]

Jalife J, Morley GE, Tallini NY & Vaidya D (1998). A fungal metabolite that eliminates motion artifacts. J Cardiovascular Electrophysiol 9, 1358–1362.[Medline]

Krucker T, Siggins GR & Halpain S (2000). Dynamic actin filaments are required for stable long-term potentiation (LTP) in area CA1 of the hippocampus. Proc Natl Acad Sci USA 97, 6856–6861.[Abstract/Free Full Text]

Lee MH, Lin SF, Ohara T, Omichi C, Okuyama Y, Chudin E, Garfinkel A, Weiss JN, Karagueuzian HS & Chen PS (2001). Effects of diacetyl monoxime and cytochalasin D on ventricular fibrillation in swine right ventricles. Am J Physiol Heart Circ Physiol 280, H2689–H2696.[Abstract/Free Full Text]

Liu Y, Cabo C, Salomonsz R, Delmar M, Davidenko J & Jalife J (1993). Effects of diacetyl monoxime on the electrical properties of sheep and guinea pig ventricular muscle. Cardiovascular Res 27, 1991–1997.[Abstract/Free Full Text]

Mubagwa K, Stengl M & Flameng W (1997). Extracellular divalent cations block a cation non-selective conductance unrelated to calcium channels in rat cardiac muscle. J Physiol 502, 235–247.[CrossRef][Medline]

Ng GA, Cobbe SM & Smith GL (1998). Non-uniform prolongation of intracellular Ca2+ transients recorded from the epicardial surface of isolated hearts from rabbits with heart failure. Cardiovascular Res 37, 489–502.[Abstract/Free Full Text]

Nitta J, Furukawa T, Marumo F, Sawanobori T & Hiraoka M (1994). Subcellular mechanism for Ca2+-dependent enhancement of delayed rectifier K+ current in isolated membrane patches of guinea pig ventricular myocytes. Circ Res 74, 96–104.[Abstract/Free Full Text]

Riccio ML, Koller ML & Gilmour RF (1999). Electrical restitution and spatiotemporal organization during ventricular fibrillation. Circ Res 84, 955–963.[Abstract/Free Full Text]

Salama G (2001). Historical perspective of optical mapping. In Optical Mapping of Cardiac Excitation and Arrhythmias, ed. Rosenbaum DS & Jalife J, pp. 9–31. Futura Publishing Company, Inc, New York.

Salama G & Choi BR (2000). Images of action potential propagation in heart. News Physiol Sci 15, 33–41.[Abstract/Free Full Text]

Schwinger RH, Bohm M, Muller-Ehmsen J, Uhlmann R, Schmidt U, Stablein A, Uberfuhr P, Kreuzer E, Reichart B & Eissner HJ (1993). Effect of inotropic stimulation on the negative force-frequency relationship in the failing human heart. Circulation 88, 2267–2276.[Abstract/Free Full Text]

Smetana P, Batchvarov VN, Hnatkova K, Camm AJ & Malik M (2002). Sex differences in repolarization homogeneity and its circadian pattern. Am J Physiol Heart Circ Physiol 282, H1889–H1897.[Abstract/Free Full Text]

Steele DS & Smith GL (1993). Effects of 2,3-butanedione monoxime on sarcoplasmic reticulum of saponin-treated rat cardiac muscle. Am J Physiol 265, H1493–H1500.

Verrecchia F & Herve JC (1997). Reversible blockade of gap junctional communication by 2,3-butanedione monoxime in rat cardiac myocytes. Am J Physiol 272, C875–C885.[Abstract/Free Full Text]

Watanabe Y, Iwamoto T, Matsuoka I, Ohkubo S, Ono T, Watano T, Shigekawa M & Kimura J (2001). Inhibitory effect of 2,3-butanedione monoxime (BDM) on Na(+)/Ca(2+) exchange current in guinea-pig cardiac ventricular myocytes. Br J Pharmacol 132, 1317–1325.[CrossRef][Medline]

Wiggins JR, Reiser J, Fitzpatrick DF & Bergey JL (1980). Inotropic actions of diacetyl monoxime in cat ventricular muscle. J Pharmacol Exp Ther 212, 217–224.[Free Full Text]


    Acknowledgements
 
The authors would like to thank the technical assistance of Anne Ward and Aileen Rankin of the University of Glasgow. This work was financially support by programme grant funding from the British Heart Foundation (BHF). NLW held a BHF clinical PhD fellowship, SK held an MRC studentship.




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
R. Veeraraghavan and S. Poelzing
Mechanisms underlying increased right ventricular conduction sensitivity to flecainide challenge
Cardiovasc Res, March 1, 2008; 77(4): 749 - 756.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Iravanian and D. J. Christini
Optical mapping system with real-time control capability
Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2605 - H2611.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
V. Y. Sidorov, M. C. Woods, and F. Baudenbacher
Cathodal stimulation in the recovery phase of a propagating planar wave in the rabbit heart reveals four stimulation mechanisms
J. Physiol., August 15, 2007; 583(1): 237 - 250.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
G. A. Ng, K. E. Brack, V. H. Patel, and J. H. Coote
Autonomic modulation of electrical restitution, alternans and ventricular fibrillation initiation in the isolated heart
Cardiovasc Res, March 1, 2007; 73(4): 750 - 760.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
89/2/163    most recent
expphysiol.2003.026732v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kettlewell, S.
Right arrow Articles by Smith, G. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kettlewell, S.
Right arrow Articles by Smith, G. L.
Related Collections
Right arrow Heart/Cardiac Muscle


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS